Live Breaking News & Updates on Collegium Pharmaceuticals

Stay updated with breaking news from Collegium pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Collegium announces authorized generic agreement with Hikma for Nucynta, Nucynta ER

Hikma will have the exclusive right to sell the authorized generic versions of Nucynta and Nucynta ER in the United States. ....

United States , Joe Ciaffoni , Collegium Pharmaceuticals , Nucynta Franchise ,

Head-To-Head Contrast: Xenon Pharmaceuticals (NASDAQ:XENE) & Collegium Pharmaceutical (NASDAQ:COLL)

Xenon Pharmaceuticals (NASDAQ:XENE – Get Free Report) and Collegium Pharmaceutical (NASDAQ:COLL – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends. Risk and Volatility Xenon Pharmaceuticals has a beta […] ....

United States , Neurocrine Biosciences Inc , Collegium Pharmaceutical Inc , Xenon Pharmaceuticals , Xenon Pharmaceuticals Inc , News Ratings For Xenon Pharmaceuticals Daily , Collegium Pharmaceuticals Inc , Get Free Report , Collegium Pharmaceutical , Given Xenon Pharmaceutical , Pharmaceuticals Inc , Neurocrine Biosciences , Collegium Pharmaceuticals , Xenon Pharmaceuticals Daily , Nasdaq Xene , Stock Comparison , Stock Analysis ,